Effect of a photoactivated rhodium complex in melanoma

Anti-Cancer Drugs

Volumn 22, Issue 9, 2011, Pages 896-904

  Kim, Mi Ran ^a,b   Morrison, Harry ^a   Mohammed, Sulma Ibrahim ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

melanoma; organometallic compounds; photoactive; phototherapy

Indexed keywords

CIS DICHLOROBIS(3,4,7,8 TETRAMETHYL 1,10 PHENANTHROLINE)RHODIUM(III)CHLORIDE; CISPLATIN; RHODIUM COMPLEX; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM TOLERATED DOSE; MELANOMA; MOUSE; NICK END LABELING; NONHUMAN; PHOTOACTIVATION; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; IN SITU NICK-END LABELING; MALE; MELANOMA; MICE; MICE, NUDE; MICE, SCID; MOLECULAR TARGETED THERAPY; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80052510958     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32834850a5     Document Type: Article

References (14)

1. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin Pharmacother 2001; 2:917-927 (Pubitemid 32750348)
2. Dougherty TJ. Introduction. Methods Mol Biol 2010; 635:1-6
3. Triesscheijn M, Ruevekamp M, Aalders M, Baas P, Stewart FA. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin. Photochem Photobiol 2004; 80:236-241
4. Du HY, Bay BH, Olivo M. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model. Int J Oncol 2003; 22:1019-1024
5. Corti L, Toniolo L, Boso C, Colaut F, Fiore D, Muzzio PC, et al. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Lasers Surg Med 2007; 39:394-402 (Pubitemid 47041088)
6. Sidoroff A, Thaler P. Taking treatment decisions in non-melanoma skin cancer: the place for topical photodynamic therapy (PDT).Photodiagnosis Photodyn Ther 2010; 7:24-32
7. Manyak MJ, Ogan K. Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium. J Endourol 2003; 17:633-639 (Pubitemid 37362913)
8. Bhuvaneswari R, Gan YY, Soo KC, Olivo M. The effect of photodynamic therapy on tumor angiogenesis. Cell Mol Life Sci 2009; 66:2275-2283
9. Menon EL, Perera R, Navarro M, Kuhn RJ, Morrison H. Phototoxicity against tumor cells and Sindbis virus by an octahedral rhodium bisbipyridyl complex and evidence for the genome as a target in viral photoinactivation. Inorg Chem 2004; 43:5373-5381
10. Loganathan D, Morrison H. Effect of ring methylation on the photophysical, photochemical and photobiological properties of cis-dichlorobis(1,10- phenanthroline)rhodium(III)chloride. Photochem Photobiol 2006; 82:237-247 (Pubitemid 43348449)
11. Wang CC, Chiang YM, Sung SC, Hsu YL, Chang JK, Kuo PL. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/ c-Jun N-terminal kinase pathways in human melanoma A375S2 cells. Cancer Lett 2008; 259:82-98 (Pubitemid 350245420)
12. Helmbach H, Rossmann E, Kern MA, Schadendorf D. Drug-resistance in human melanoma. Int J Cancer 2001; 93:617-622 (Pubitemid 32695107)
13. Mohammed SI, Dhawan D, Abraham S, Snyder PW, Waters DJ, Craig BA, et al. Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects. Mol Cancer Ther 2006; 5:329-336
14. Fruehauf JP, Trapp V. Reactive oxygen species: an Achilles' heel of melanoma? Expert Rev Anticancer Ther 2008; 8:1751-1757,